Blasco-Santana L, Colmenero I
Int J Mol Sci. 2024; 25(15).
PMID: 39126064
PMC: 11312892.
DOI: 10.3390/ijms25158498.
Hayashi N, Fukai J, Nakatogawa H, Kawaji H, Yoshioka E, Kodama Y
Acta Neuropathol Commun. 2024; 12(1):120.
PMID: 39061104
PMC: 11282756.
DOI: 10.1186/s40478-024-01808-w.
Fernando D, Ahmed A, Williams B
Front Oncol. 2024; 14:1347694.
PMID: 38525424
PMC: 10957575.
DOI: 10.3389/fonc.2024.1347694.
Marastoni E, Ammendola S, Rossi S, Giovannoni I, Broggi G, Masotto B
Virchows Arch. 2024; .
PMID: 38233563
DOI: 10.1007/s00428-024-03739-2.
Auffret L, Ajlil Y, Tauziede-Espariat A, Kergrohen T, Puiseux C, Riffaud L
Acta Neuropathol. 2023; 147(1):2.
PMID: 38066305
PMC: 10709479.
DOI: 10.1007/s00401-023-02651-4.
Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations.
Roberts H, Ji S, Picca A, Sanson M, Garcia M, Snuderl M
Acta Neuropathol. 2023; 146(6):849-852.
PMID: 37851269
PMC: 10627895.
DOI: 10.1007/s00401-023-02640-7.
H3K27M mutant glioma: Disease definition and biological underpinnings.
Saratsis A, Knowles T, Petrovic A, Nazarian J
Neuro Oncol. 2023; 26(Supplement_2):S92-S100.
PMID: 37818718
PMC: 11066930.
DOI: 10.1093/neuonc/noad164.
Midline Gliomas: A Retrospective Study from a Cancer Center in the Middle East.
Al Sharie S, Abu Laban D, Nazzal J, Iqneibi S, Ghnaimat S, Al-Ani A
Cancers (Basel). 2023; 15(18).
PMID: 37760513
PMC: 10527416.
DOI: 10.3390/cancers15184545.
Frontal lobe mass in a 46-year-old woman.
Zhang K, Ramlal B, Schreck K, Eberhart C, Lucas C
Brain Pathol. 2023; 34(1):e13211.
PMID: 37712207
PMC: 10711255.
DOI: 10.1111/bpa.13211.
Molecular neuropathology: an essential and evolving toolbox for the diagnosis and clinical management of central nervous system tumors.
Bertero L, Mangherini L, Ricci A, Cassoni P, Sahm F
Virchows Arch. 2023; 484(2):181-194.
PMID: 37658995
PMC: 10948579.
DOI: 10.1007/s00428-023-03632-4.
Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways.
Venneti S, Kawakibi A, Ji S, Waszak S, Sweha S, Mota M
Cancer Discov. 2023; 13(11):2370-2393.
PMID: 37584601
PMC: 10618742.
DOI: 10.1158/2159-8290.CD-23-0131.
Pediatric brain tumors: A neuropathologist's approach to the integrated diagnosis.
Viaene A
Front Pediatr. 2023; 11:1143363.
PMID: 36969278
PMC: 10030595.
DOI: 10.3389/fped.2023.1143363.
Primary spinal intramedullary anaplastic ganglioglioma in a pediatric patient.
Dang H, Khan A, Gadgil N, Prablek M, Lin F, Blessing M
Surg Neurol Int. 2023; 14:55.
PMID: 36895253
PMC: 9990802.
DOI: 10.25259/SNI_825_2022.
Clinical, histopathological and molecular risk factors for recurrence of pilocytic astrocytomas: brainstem/spinal location, nestin expression and gain of 7q and 19 are associated with early tumor recurrence.
Tamura R, Iwanami A, Ohara K, Nishimoto M, Pareira E, Miwa T
Brain Tumor Pathol. 2023; 40(2):109-123.
PMID: 36892668
DOI: 10.1007/s10014-023-00453-w.
Events in CNS Tumor Pathology Post-2016 WHO CNS: cIMPACT-NOW Updates and Other Advancements: A Comprehensive Review Plus a Summary of the Salient Features of 2021 WHO CNS 5.
Ahmad Z, Rahim S, Abdul-Ghafar J, Chundriger Q, Ud Din N
Int J Gen Med. 2023; 16:107-127.
PMID: 36644568
PMC: 9833325.
DOI: 10.2147/IJGM.S394872.
Spinal Cord Diffuse Midline Glioma, H3K27M- mutant Effectively Treated with Bevacizumab: A Report of Two Cases.
Yabuno S, Kawauchi S, Umakoshi M, Uneda A, Fujii K, Ishida J
NMC Case Rep J. 2022; 8(1):505-511.
PMID: 35079510
PMC: 8769434.
DOI: 10.2176/nmccrj.cr.2021-0033.
Emerging glioneuronal and neuronal tumors: case-based review.
Lim S, Kim S, Park J, Won J, Kim S, Phi J
Brain Tumor Pathol. 2022; 39(2):65-78.
PMID: 35048219
DOI: 10.1007/s10014-021-00420-3.
Advanced Magnetic Resonance Imaging in Pediatric Glioblastomas.
Goncalves F, Viaene A, Vossough A
Front Neurol. 2021; 12:733323.
PMID: 34858308
PMC: 8631300.
DOI: 10.3389/fneur.2021.733323.
Deciphering the genetic and epigenetic landscape of pediatric bithalamic tumors.
Tauziede-Espariat A, Debily M, Castel D, Grill J, Puget S, Roux A
Brain Pathol. 2021; 32(3):e13039.
PMID: 34854160
PMC: 9048515.
DOI: 10.1111/bpa.13039.
Accuracy of central neuro-imaging review of DIPG compared with histopathology in the International DIPG Registry.
Lazow M, Fuller C, DeWire M, Lane A, Bandopadhayay P, Bartels U
Neuro Oncol. 2021; 24(5):821-833.
PMID: 34668975
PMC: 9071293.
DOI: 10.1093/neuonc/noab245.
